KYLE LUMSDEN: Open Payments
NPI 1487326963 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 36 payments from 13 companies in 2025. Trend: 2023 $519 · 2024 $1,307 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $212 |
| ABBVIE INC. | 10 | $152 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| PFIZER INC. | 5 | $109 |
| Genentech USA, Inc. | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Cycle Pharmaceuticals Inc | 2 | $52 |
| Lundbeck LLC | 2 | $44 |
| ACADIA Pharmaceuticals Inc | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: FANAPT, WATCHMAN FLX, NURTEC ODT, General - DBS, QULIPTA, AUSTEDO XR, Bafiertam, UBRELVY.
Industry payments across HI — which companies pay providers there.
